Celsius (NASDAQ: CELH) recently received a number of ratings updates from brokerages and research firms:
- 12/16/2024 – Celsius had its price target lowered by analysts at Roth Mkm from $40.00 to $38.00. They now have a “buy” rating on the stock.
- 12/12/2024 – Celsius is now covered by analysts at JPMorgan Chase & Co.. They set an “overweight” rating and a $37.00 price target on the stock.
- 12/12/2024 – Celsius is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “hold” rating and a $32.00 price target on the stock.
- 12/6/2024 – Celsius is now covered by analysts at Needham & Company LLC. They set a “buy” rating and a $38.00 price target on the stock.
- 11/7/2024 – Celsius had its price target lowered by analysts at Stifel Nicolaus from $51.00 to $45.00. They now have a “buy” rating on the stock.
- 11/7/2024 – Celsius had its price target lowered by analysts at Roth Mkm from $43.00 to $40.00. They now have a “buy” rating on the stock.
- 11/7/2024 – Celsius had its price target lowered by analysts at UBS Group AG from $50.00 to $45.00. They now have a “buy” rating on the stock.
- 11/4/2024 – Celsius had its price target lowered by analysts at B. Riley from $50.00 to $47.00. They now have a “buy” rating on the stock.
- 10/21/2024 – Celsius had its price target lowered by analysts at LADENBURG THALM/SH SH from $72.00 to $68.00. They now have a “neutral” rating on the stock.
Celsius Price Performance
CELH opened at $29.24 on Wednesday. Celsius Holdings, Inc. has a 1-year low of $25.23 and a 1-year high of $99.62. The stock has a market cap of $6.87 billion, a P/E ratio of 40.61, a P/E/G ratio of 3.44 and a beta of 1.76. The stock’s 50 day simple moving average is $30.09 and its 200 day simple moving average is $40.83.
Insider Buying and Selling
In other Celsius news, major shareholder William H. Milmoe sold 65,000 shares of the firm’s stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $31.15, for a total value of $2,024,750.00. Following the sale, the insider now directly owns 261,245 shares of the company’s stock, valued at approximately $8,137,781.75. This trade represents a 19.92 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 2.20% of the company’s stock.
Institutional Investors Weigh In On Celsius
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
See Also
- Five stocks we like better than Celsius
- Market Cap Calculator: How to Calculate Market Cap
- AppLovin Insiders Sell Shares: Stock Price Indicated Higher
- How Investors Can Find the Best Cheap Dividend Stocks
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Salesforce’s Clear Path to $400 and Beyond
Receive News & Ratings for Celsius Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.